FDA Holds on Imported Products Can Be Subjective, Experts Say

Washington Drug Letter
KEYWORDS FDA
A A
Decisions on banning imported products can be based on a variety of factors, so companies must be prepared to challenge an import hold with the FDA, industry experts said at an FDAnews audioconference.

To View This Article:

Login